{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": -2.9411798, "regularMarketPrice": 0.561, "exchange": "FRA", "shortName": "NICOX SA INH.  EO 1", "longName": "Nicox S.A.", "messageBoardId": "finmb_131325", "exchangeTimezoneName": "Europe/Berlin", "market": "dr_market", "regularMarketTime": 1683880220, "regularMarketDayHigh": 0.561, "regularMarketDayRange": "0.561 - 0.561", "regularMarketDayLow": 0.561, "regularMarketVolume": 45, "regularMarketPreviousClose": 0.578, "bid": 0.561, "ask": 0.626, "bidSize": 2000, "askSize": 2000, "fullExchangeName": "Frankfurt", "financialCurrency": "EUR", "regularMarketOpen": 0.561, "averageDailyVolume3Month": 69, "averageDailyVolume10Day": 352, "fiftyTwoWeekLowChange": 0.020999968, "fiftyTwoWeekLowChangePercent": 0.038888827, "fiftyTwoWeekRange": "0.54 - 2.01", "fiftyTwoWeekHighChange": -1.449, "fiftyTwoWeekHighChangePercent": -0.7208955, "fiftyTwoWeekLow": 0.54, "fiftyTwoWeekHigh": 2.01, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.25, "sharesOutstanding": 50156700, "bookValue": 1.405, "fiftyDayAverage": 0.65778, "fiftyDayAverageChange": -0.09678, "fiftyDayAverageChangePercent": -0.14713126, "twoHundredDayAverage": 1.291955, "twoHundredDayAverageChange": -0.730955, "twoHundredDayAverageChangePercent": -0.5657744, "marketCap": 28137908, "priceToBook": 0.39928827, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 969948000000, "priceHint": 4, "regularMarketChange": -0.01700002, "symbol": "NXOA.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2405 Route Des Dolines Drakkar D", "city": "Valbonne", "zip": "06560", "country": "France", "phone": "33 4 97 24 53 00", "fax": "33 4 97 24 53 99", "website": "https://www.nicox.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Nicox S.A. operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating prostaglandin analog for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in phase 3 clinical trial. The company is also developing NCX 4251, a proprietary formulation of fluticasone for acute exacerbations of blepharitis that is in a Phase 2b clinical trial for the treatment of acute exacerbations of blepharitis; and NCX 1728.It offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis. The company was founded in 1996 and is headquartered in Valbonne, France.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Michele  Garufi Ph.D.", "age": 68, "title": "Co-Founder & Director", "yearBorn": 1954, "fiscalYear": 2021, "totalPay": {"raw": 475450, "fmt": "475.45k", "longFmt": "475,450"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andreas Rutger Segerros M.B.A., M.Sc.", "age": 62, "title": "Chief Exec. Officer", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sandrine  Gestin", "age": 55, "title": "VP of Fin.", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Doug  Hubatsch", "age": 55, "title": "Exec. VP & Chief Scientific Officer", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Emmanuelle  Pierry", "age": 53, "title": "Gen. Counsel & Head of Legal Affairs", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Gavin M. Spencer", "age": 52, "title": "Exec. VP, Chief Bus. Officer & Head of Corp. Devel.", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ramesh  Krishnamoorthy", "title": "Sr. Director and Head of Late Stage CMC & Quality Control", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jose  Boyer", "title": "Consultant", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}